PEREGRINE CAPITAL MANAGEMENT LLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
PEREGRINE CAPITAL MANAGEMENT LLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2021$6,340,000
-33.3%
126,613
-16.2%
0.13%
-23.4%
Q2 2021$9,511,000
-34.4%
151,000
-3.3%
0.17%
-36.4%
Q1 2021$14,504,000
-8.5%
156,113
-11.7%
0.27%
-10.6%
Q4 2020$15,849,000
+4.6%
176,891
+20.6%
0.30%
-25.1%
Q3 2020$15,151,000
-13.0%
146,625
-33.4%
0.40%
-18.8%
Q2 2020$17,405,000
+22.7%
220,088
-10.2%
0.50%
-2.6%
Q1 2020$14,187,000
-11.8%
245,195
-17.7%
0.51%
+23.9%
Q4 2019$16,080,000
+2.0%
298,045
-1.1%
0.41%
-4.4%
Q3 2019$15,762,000
+0.7%
301,487
-6.9%
0.43%
+11.1%
Q2 2019$15,647,000
+3.9%
323,885
+8.7%
0.39%
+2.4%
Q1 2019$15,059,000
-5.1%
298,086
+11.3%
0.38%
-15.7%
Q4 2018$15,872,000
-22.3%
267,740
-13.7%
0.45%
-7.6%
Q3 2018$20,421,000
+22.7%
310,213
-5.9%
0.48%
+16.3%
Q2 2018$16,643,000
-9.4%
329,620
-5.5%
0.42%
-7.3%
Q1 2018$18,373,000
+8.0%
348,968
-4.7%
0.45%
+12.2%
Q4 2017$17,016,000
-7.5%
366,170
-19.5%
0.40%
-9.3%
Q3 2017$18,399,000
+67.9%
454,857
+40.8%
0.44%
+61.5%
Q2 2017$10,959,000
+15.1%
323,165
-0.3%
0.27%
+12.8%
Q1 2017$9,521,000
-4.0%
324,077
+7.4%
0.24%
-5.8%
Q4 2016$9,913,000301,8450.26%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,080,519$44,336,0004.65%
GREAT POINT PARTNERS LLC 290,000$6,180,0002.65%
FIDUCIARY MANAGEMENT ASSOCIATES LLC 651,884$13,892,0000.99%
Matarin Capital Management, LLC 85,003$1,811,414,0000.83%
KINGDON CAPITAL MANAGEMENT, L.L.C. 407,000$8,673,0000.39%
ICON ADVISERS INC/CO 258,478$5,508,0000.32%
RMB Capital Management, LLC 178,204$3,798,0000.23%
NEW AMSTERDAM PARTNERS LLC/NY 159,470$3,398,0000.23%
GLOBEFLEX CAPITAL L P 94,016$2,003,0000.23%
Convergence Investment Partners, LLC 58,672$1,250,0000.17%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders